Achilles Therapeutics plc (ACHL) Social Stream
ACHILLES THERAPEUTICS PLC (ACHL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ACHILLES THERAPEUTICS PLC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $27 | $6 | $19 | $0.94 | 1921.28% |
| 2022-03-02 | 5 | $27 | $7 | $19.2 | $0.94 | 1942.55% |
| 2022-03-03 | 5 | $27 | $7 | $17.8 | $0.94 | 1793.62% |
| 2022-03-31 | 5 | $27 | $7 | $17.4 | $0.94 | 1751.06% |
| 2022-05-11 | 5 | $27 | $7 | $16.8 | $0.94 | 1687.23% |
| 2022-05-27 | 5 | $20 | $7 | $14.4 | $0.94 | 1431.91% |
| 2022-08-13 | 5 | $20 | $7 | $13 | $0.94 | 1282.98% |
| 2022-11-11 | 5 | $20 | $7 | $12.8 | $0.94 | 1261.7% |
| 2023-01-25 | 5 | $17 | $7 | $10 | $0.94 | 963.83% |
| 2023-02-08 | 5 | $17 | $8 | $11 | $0.94 | 1070.21% |
| 2023-03-07 | 4 | $17 | $8 | $11 | $0.94 | 1070.21% |
| 2023-05-10 | 4 | $12 | $7 | $9 | $0.94 | 857.45% |
| 2023-05-16 | 4 | $11 | $7 | $8.666 | $0.94 | 821.91% |
| 2023-11-14 | 3 | $11 | $7 | $8.666 | $0.94 | 821.91% |
| 2023-12-14 | 3 | $11 | $0.5 | $6.5 | $0.94 | 591.49% |
The Trend in the Analyst Price Target
Over the past 15 months, ACHL's average price target has gone down $6.3.
ACHL reports an average of 806.27% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-10 | 4 | 12 | 7 | 9.000 | 0.951 | 846.37% |
| 2023-05-11 | 4 | 11 | 7 | 8.666 | 0.953 | 809.34% |
| 2023-06-28 | 3 | 11 | 7 | 8.666 | 0.980 | 784.29% |
| 2023-08-07 | 3 | 11 | 7 | 8.666 | 1.010 | 758.02% |
| 2023-11-14 | 3 | 11 | 7 | 8.666 | 0.810 | 969.88% |
ACHL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ACHL's average broker recommendation rating worsened by 0.2 over the prior 26 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ACHILLES THERAPEUTICS PLC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1562.81% of that group.
- To contextualize these metrics, consider that out of all US stocks, ACHILLES THERAPEUTICS PLC's average analyst price target is higher than 247.08% of them.
- In terms of how ACHILLES THERAPEUTICS PLC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -1171.05% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, ACHILLES THERAPEUTICS PLC's number of analysts covering the stock is higher than 345.69% of them.
In the Pharmaceutical Products industry, GLUE, ELEV, and GRPH are the three stocks most similar to ACHILLES THERAPEUTICS PLC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ACHL a Buy, Hold or Sell? See the POWR Ratings now!